These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6347619)

  • 1. Drug interactions with warfarin.
    Serlin MJ; Breckenridge AM
    Drugs; 1983 Jun; 25(6):610-20. PubMed ID: 6347619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of oral anticoagulants.
    Kelly JG; O'Malley K
    Clin Pharmacokinet; 1979; 4(1):1-15. PubMed ID: 369763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin metabolism and drug-drug interactions.
    O'Reilly RA
    Adv Exp Med Biol; 1987; 214():205-12. PubMed ID: 3310541
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.
    MacLeod SM; Sellers EM
    Drugs; 1976; 11(6):461-70. PubMed ID: 782840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of liver cytochrome P450s by Danshen-Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin.
    Zhang Z; Ge B; Zhou L; Lam TN; Zuo Z
    J Ethnopharmacol; 2014 Jul; 154(3):672-86. PubMed ID: 24832110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of warfarin with drugs and food.
    Wells PS; Holbrook AM; Crowther NR; Hirsh J
    Ann Intern Med; 1994 Nov; 121(9):676-83. PubMed ID: 7944078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The problems of anticoagulant control. 1. Drug interactions.
    Hamblin TJ
    Bristol Med Chir J; 1970 Oct; 85(316):101-4. PubMed ID: 4992630
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1.
    Bjornsson TD; Meffin PJ; Swezey SE; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):322-6. PubMed ID: 480184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
    Palareti G; Legnani C
    Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):72-9. PubMed ID: 6491976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: mechanisms, clinical significance, and avoidance.
    Chan TY
    Ann Pharmacother; 1995 Dec; 29(12):1274-83. PubMed ID: 8672833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions and clinical pharmacokinetics.
    Kristensen MB
    Clin Pharmacokinet; 1976; 1(5):351-72. PubMed ID: 797504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.
    Ooi QX; Wright DFB; Tait RC; Isbister GK; Duffull SB
    Clin Pharmacokinet; 2017 Dec; 56(12):1555-1566. PubMed ID: 28409488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interactions between glucocorticoids and warfarin in chronic inflammatory (autoimmune) diseases].
    Hromádková L; Vlček J
    Vnitr Lek; 2012 May; 58(5):354-6. PubMed ID: 22716170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy.
    Takada T; Yamanashi Y; Konishi K; Yamamoto T; Toyoda Y; Masuo Y; Yamamoto H; Suzuki H
    Sci Transl Med; 2015 Feb; 7(275):275ra23. PubMed ID: 25696002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
    Mosterd JJ; Thijssen HH
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K and the oral anticoagulant drugs.
    O'Reilly RA
    Annu Rev Med; 1976; 27():245-61. PubMed ID: 779597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
    Wittkowsky AK
    Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interactions.
    Nies AS
    Med Clin North Am; 1974 Sep; 58(5):965-75. PubMed ID: 4607406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.